Table 2.
The detection of ASF DNA in relevant matrices or specific anti-ASFV antibodies in the respective trial period.
| Trial | Blood | Blood Mean Ct (±SD) |
Oral Swabs | Oral Swab Mean Ct (±SD) |
Rectal Swabs | Rectal Swab Mean Ct (±SD) |
Seropositive Animals |
Maximum Antibodies Titer (log10/mL) |
|---|---|---|---|---|---|---|---|---|
| T1 (Arm07) |
6/6 | 26.6 (±7.4) | 5/6 | 35.1 (±2.3) | 5/6 | 34.1 (±3.5) | 1/6 | 4.0 |
| T2 (Pol18) |
6/7 | 23.7 (±5.0) | 4/7 | 36.2 (±2.2) | 7/7 | 34.3 (±3.3) | 1/7 | 4.11 |
| T3 (NH/P68) |
4/6 | 38.3 (±1.2) | 5/6 | 36.6 (±2.4) | 3/6 | 38.0 (±1.4) | 6/6 | 5.0 |